GGG

GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038

Inga transaktioner
Se i superdiagram

GSK.GJ analysis



GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 risks and ratings


Below, we've gathered key metrics for GSK.GJ risk analysis: see the bond security level, means of inflation protection, issuer rating, and more to evaluate how reliable the GSK.GJ bonds are and make an informed decision.
See what analysts are saying
Gain access to exclusive analysts ratings for bonds including risks, ratings, and more.

Agents


Agents
Role
Commitment amount